Press release: Vital stem cell research stands protected by European Commission
28 May 2014
The League of European Research Universities (LERU) is pleased with the position that the European Commission has taken in its response to the European Citizens’ Initiative “One of us”.
With its Communication released today, the European Commission has now fortunately halted this initiative which, if successful, would have severely hampered or stopped vital research performed in the EU’s research funding programme Horizon 2020.
Stem cell research, in particular, is absolutely crucial to deliver better treatments for such diseases as Parkinsons and diabetes and for organ replacement.
The current provisions in Horizon 2020 already impose very strict but necessary and correct rules, limitations, exclusions and other checks on such research. They will now, as they should, continue to be upheld, in Horizon 2020, so that medical research can continue and will hopefully secure breakthroughs in these areas where Europe is a world leader.
It is of vital importance to recognise and support scientific research involving embryonic stem cells in the interest of health, well-being, prosperity and social cohesion for all citizens of Europe.
For questions please contact Prof. Kurt Deketelaere, Secretary-General LERU:
Media contact - Bart Valkenaers, Press and Communications Officer: